NCT04147078View on ClinicalTrials.gov

Personalized DC Vaccine for Postoperative Cancer

PHASE1RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

June 1, 2019

Primary Completion Date

December 31, 2025

Study Completion Date

June 1, 2026

Conditions
Gastric CancerHepatocellular CarcinomaNon-Small-Cell Lung CancerColon Rectal Cancer
Interventions
BIOLOGICAL

DC vaccine subcutaneous administration

subcutaneous administration

Trial Locations (1)

610041

RECRUITING

Qiu Li, Chengdu

All Listed Sponsors
lead

Sichuan University

OTHER

NCT04147078 - Personalized DC Vaccine for Postoperative Cancer | Biotech Hunter | Biotech Hunter